Adjusted comparison of outcomes between patients from CARTITUDE-1 versus multiple myeloma patients with prior exposure to proteasome inhibitors, immunomodulatory drugs and anti-CD38 antibody from the prospective, multinational LocoMMotion study of real-world clinical practice
- Mateos, M.-V.
- Weisel, K.
- Martin, T.
- Berdeja, J.G.
- Jakubowiak, A.
- Stewart, A.K.
- Jagannath, S.
- Lin, Y.
- Diels, J.
- Ghilotti, F.
- Thilakarathne, P.
- Perualila, N.J.
- Cabrieto, J.
- Haefliger, B.
- Erler-Yates, N.
- Hague, C.
- Jackson, C.C.
- Schecter, J.M.
- Strulev, V.
- Nesheiwat, T.
- Pacaud, L.
- Einsele, H.
- Moreau, P.
ISSN: 1592-8721
Año de publicación: 2023
Volumen: 108
Número: 8
Páginas: 2192-2204
Tipo: Artículo